Press release
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancements In The Anti-Parkinson Drugs Market
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in 2025, reflecting a CAGR of 6.9%. This expansion in the past can be linked to an aging population, rising disease occurrence, improved healthcare systems, and progress in scientific research.
The anti-parkinson drugs market size is expected to experience strong growth in the next few years. It will increase to $13.73 billion by 2029 at a compound annual growth rate (CAGR) of 5.5%. Growth is driven by increased awareness, biotechnological advancements, and the expansion of emerging markets. Key trends include investment in R&D, personalized medicine, disease-modifying therapies, drug repurposing, telemedicine, remote monitoring, biosimilars, and research collaborations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3462
What Are the High-Growth Segments in the Anti-Parkinson Drugs Market?
The anti-parkinson drugs market covered in this report is segmented -
1) By Drugs Class: Levodopa Or Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs
2) By Route of Administration: Oral, Injection, Transdermal
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies
Subsegments:
1) By Levodopa Or Carbidopa: Immediate-Release Levodopa Or Carbidopa, Extended-Release Levodopa Or Carbidopa
2) By Dopamine Receptor Agonists: Pramipexole, Ropinirole, Rotigotine
3) By Monoamine Oxidase Type B (MAO-B) Inhibitors: Selegiline, Rasagiline, Safinamide
4) By Catechol-O-Methyltransferase (COMT)-Inhibitors: Entacapone, Tolcapone
5) By Anticholinergics: Benztropine, Trihexyphenidyl
6) By Other Drugs: Amantadine, Apomorphine
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp
What Key Drivers Are Expected to Influence Future Anti-Parkinson Drugs Market Growth?
The rise in the elderly population and increased cases of Parkinson's disease are expected to elevate demand in the anti-Parkinson drugs market. Parkinson's is more prevalent in individuals over 60 years old. For example, the WHO stated in October 2022 that by 2030, one in six people globally will be aged 60 or older, with the number doubling to 2.1 billion by 2050. This demographic shift supports ongoing market growth.
Which Companies Hold the Largest Share Across Different Anti-Parkinson Drugs Market Segments?
Major companies operating in the anti-parkinson drugs market include GlaxoSmithKline plc, Pfizer Inc., Merck Co., Novartis AG, F. Hoffmann-La Roche AG, UCB S.A, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Mylan NV, C.H. Boehringer Sohn AG & Co. KG, Orion Pharma Ltd., ACADIA Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., US WorldMeds LLC, Zydus Lifesciences Limited, Chemical Industrial & Pharmaceutical Laboratories Ltd., Strides Shasun Ltd., Axcan Pharma Inc., Upsher-Smith Laboratories LLC, H. Lundbeck A/S, Vertical Pharmaceuticals LLC, Zambon SPA, M Somerset Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc.
What Trends Are Driving Growth in The Anti-Parkinson Drugs Market?
Companies in the anti-Parkinson drugs market are focusing on creating advanced therapies that address motor fluctuations and dyskinesia, common symptoms of Parkinson's disease. For example, AbbVie Inc. launched PRODUODOPA in January 2024, a 24-hour subcutaneous infusion therapy that aims to manage severe motor fluctuations and improve symptom control for patients with advanced Parkinson's disease.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report
What Are the Emerging Geographies for The Anti-Parkinson Drugs Market Growth?
North America was the largest region in the anti-Parkinson drugs market in 2023. Middle East is expected to be the fastest-growing region in the anti-parkinson drugs market during the forecast period. The regions covered in the anti-parkinson drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anti-Parkinson Drugs Market?
2. What is the CAGR expected in the Anti-Parkinson Drugs Market?
3. What Are the Key Innovations Transforming the Anti-Parkinson Drugs Industry?
4. Which Region Is Leading the Anti-Parkinson Drugs Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancements In The Anti-Parkinson Drugs Market here
News-ID: 4050252 • Views: …
More Releases from The Business Research Company
Segment Analysis and Major Growth Areas in the Ice Detection System Market
The ice detection system market is gaining attention as industries seek improved safety and efficiency in cold environments. With technological advancements and growing demand from various sectors, this market is set for steady expansion in the coming years. Here is an in-depth look at the market's valuation, major players, key trends, and segmentation details.
Projected Growth and Value of the Ice Detection System Market by 2030
The ice detection system market…
Global Trends Overview: The Rapid Evolution of the Hydrogen Aircraft Market
The hydrogen aircraft sector is poised for remarkable expansion as the aviation industry increasingly pursues sustainable and innovative solutions. With growing environmental concerns and technological advancements, hydrogen-powered aviation is gaining momentum and attracting significant investments. Below, we explore the market size projections, key players, emerging trends, and segment classifications shaping this promising industry.
Expected Market Size and Growth Potential of the Hydrogen Aircraft Market
The hydrogen aircraft market is projected to…
Segment Analysis and Major Growth Areas in the Hong Kong Aircraft Engineering Co …
The aviation seating industry is undergoing significant transformation as manufacturers and airlines strive to enhance passenger comfort while improving operational efficiency. One noteworthy segment experiencing rapid development is the Hong Kong Aircraft Engineering Company Limited (HAECO) Vector Light market, which is gaining traction due to advances in lightweight seating solutions and evolving cabin design preferences. Below is an in-depth overview of this market's growth prospects, key players, emerging trends, and…
Global Trends Analysis: The Rapid Evolution of the High-Energy Microwave C-Unman …
The high-energy microwave C-unmanned aircraft system (UAS) market is gathering significant momentum as it moves toward a promising future. Driven by technological breakthroughs and expanding defense needs, this sector is set to reshape how unmanned platforms and counter-drone measures evolve. Below, we explore the market's anticipated growth, leading participants, emerging trends, and key segments shaping its trajectory.
Market Size and Growth Outlook for the High-Energy Microwave C-Unmanned Aircraft System Market
The…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
